Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute To Autoimmune Addison's Disease and Graves' Disease Susceptibility

2010 ◽  
Vol 2010 ◽  
pp. 126-128
Author(s):  
M. Schott
2009 ◽  
Vol 94 (12) ◽  
pp. 5139-5145 ◽  
Author(s):  
Anna L. Mitchell ◽  
Heather J. Cordell ◽  
Rachel Soemedi ◽  
Kate Owen ◽  
Beate Skinningsrud ◽  
...  

2009 ◽  
Vol 23 (11) ◽  
pp. 1935-1935
Author(s):  
Anna L. Mitchell ◽  
Heather J. Cordell ◽  
Rachel Soemedi ◽  
Kate Owen ◽  
Beate Skinningsrud ◽  
...  

1924 ◽  
Vol 40 (3) ◽  
pp. 325-342 ◽  
Author(s):  
Henry L. Jaffe

Experimental evidence has been presented showing that the thymus gland of the rat enlarges rapidly in those animals surviving double suprarenalectomy. The enlargement has been observed to follow bilateral ablation with such constancy that it may be said to occur in all rats which survive double suprarenalectomy in good condition for from 3 to 5 weeks. The thymus enlarges even though the animal loses some weight after operation. Our data, though inconclusive, would seem to indicate a sex difference, the secondary hyperplasia of the thymus being more marked in the female than in the male. This difference, we believe, may shed some light on the mechanism of thymus enlargement following double suprarenalectomy. In the rat there is a definite sex difference in the weight of the suprarenals (20), the glands being much larger in the female than in the male. This weight difference becomes greater as the rat grows, and it appears at an early period of life; indeed, it is obvious at about 35 days of age, in spite of the fact that sexual maturity is seldom attained before 60 to 90 days. This difference in the suprarenals is independent of pregnancy. It is highly probable that the suprarenal glands stand in closer relation to the sex organs of the females than in the male, and that removal of these glands disrupts the sex interrelationships between gonads, suprarenals, and thymus, this disturbance being more definitely expressed in the female than in the male. The great majority of the rats were operated on when they were between 6 and 7 months of age; that is, after thymus involution would normally have set in. Thymuses examined when they had reached their largest size resembled both grossly and microscopically the growing thymuses of much younger animals, the only evidence of previous involutionary change being the presence of thickening of the vessels. We assume, therefore, from indirect, but statistical data, that regeneration of the involuted thymus must have taken place. The regeneration following bilateral ablation describes a curve which reaches its height between the 3rd and 5th weeks after operation. After the height of enlargement is attained, there is a gradual decline in the size of the gland, but involutionary changes may be retarded for months. Pregnancy prior to suprarenalectomy does not prevent thymus regeneration following this operation. Thymic enlargement does not ordinarily take place following a unilateral ablation. Severe chronic infections may sometimes bring about such a pronounced pathological involution of the thymus that the hyperplasia may be prevented. There can as yet be only speculation as to the mechanism involved in the regeneration of the thymus which follows suprarenalectomy. This secondary thymic hyperplasia may be one manifestation of the generalized lymphoid hyperplasia that follows sublethal but sufficient suprarenal injury, and which is characterized by the appearance of prominent lymphoid foci in the various organs, particularly in the thyroid, a generalized hyperplasia of the lymph nodes and bone marrow, and the appearance of a lymphocytosis in the blood. The evidence at present available would suggest that both the thymic and general lymphoid hyperplasia may be effected through the gonads and parasex tissues and that the thymus especially regenerates because of a disruption of the interrelations between the interrenal gland, the gonads, and the thymus. The close association between the gonads and the suprarenals (21) is well known. The latter undergo enlargement in pregnancy, ovulation, and castration, and the ovaries hypertrophy after suprarenalectomy. Tumors of the suprarenals are associated frequently with sex perversion and precocity both in the male and female. The interrelation between the gonads and thymus is classical, castration before puberty delaying thymus involution for a long time. A number of diseases present thymus enlargement among the major pathological findings at autopsy. The most outstanding of these are Addison's disease, status lymphaticus, and Graves' disease. It is now generally recognized that the suprarenal glands play an important r61e in the etiology both of Addison's disease and status lymphaticus. Whether the interrenal or the chromophil system is primarily involved or whether disturbances in function of both systems are at the basis of these diseases is still undetermined. The newer evidence, including our own work on lymphoid regeneration following suprarenalectomy supports the view that the lymphoid hyperplasia occurring in both Addison's disease and status lymphaticus is dependent upon insufficiency of the interrenal system (suprarenal cortex). While anatomical studies have not disclosed any constant lesions in the suprarenals in Graves' disease, evidence is being accumulated which would indicate that functionally these glands also play an important if not a primary role in the production of the clinical syndrome of Graves' disease (14, 18, 19). We are of the belief that the persistence of the thymus which occurs in status lymphaticus, and the regeneration which occurs in Addison's and Graves' diseases, are brought about by the same disturbances in glandular interrelations which bring about regeneration of the thymus in the experimental animal after suprarenalectomy.


2007 ◽  
Vol 92 (8) ◽  
pp. 3338-3341 ◽  
Author(s):  
Alison Sutherland ◽  
Jocelyn Davies ◽  
Catherine J. Owen ◽  
Suresh Vaikkakara ◽  
Christine Walker ◽  
...  

Abstract Context: A recent large-scale analysis of nonsynonymous coding polymorphisms showed strong evidence that an alanine to threonine amino acid change at codon 946 of the interferon-induced helicase (IFIH1) gene (SNP ID rs1990760) was associated with type 1 diabetes. Previous investigations have also demonstrated that an intronic polymorphism (termed PD1.3; SNP ID rs11568821) in the programmed cell death (PDCD1) gene was associated with systemic lupus erythematosus and rheumatoid arthritis. Objective: We sought to replicate these genetic associations in Graves’ disease and autoimmune Addison’s disease patient cohorts. Patients and Methods: A total of 602 Graves’ disease subjects, 214 Addison’s disease subjects, and 446 healthy controls were genotyped for the IFIH1 and PDCD1 single-nucleotide polymorphisms using mass spectrometer analysis of primer extension products (Sequenom). Results: The alanine-carrying allele at the IFIH1 codon 946 polymorphism was present in 796 of 1204 (66%) Graves’ disease patient alleles compared with 508 of 892 (57%) control subject alleles [odds ratio 1.47 (5–95% confidence interval, 1.23–1.76); P = 1.9 × 10−5]. In contrast, there was no association of alleles at this marker in autoimmune Addison’s disease. Neither was there evidence for association in either patient cohort at the PD1.3 polymorphism. Conclusions: We confirm a significant contribution of the Ala946Thr IFIH1 polymorphism to organ-specific autoimmune diseases, extending the range of conditions associated with this variant to include Graves’ disease. This polymorphism may also contribute to several other autoimmune disorders.


2004 ◽  
pp. 193-197 ◽  
Author(s):  
ER Lopez ◽  
O Zwermann ◽  
M Segni ◽  
G Meyer ◽  
M Reincke ◽  
...  

BACKGROUND: CYP27B1 hydroxylase catalyzes the conversion of 25 hydroxyvitamin D(3) (25OHD(3)) to 1,25(OH)(2)D(3), the most active natural vitamin D metabolite, which plays a role in the regulation of immunity and cell proliferation. We therefore investigated two single nucleotide polymorphisms in the CYP27B1 hydroxylase gene for an association with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus. METHODS: Patients with Addison's disease (n=124), Hashimoto's thyroiditis (n=139), Graves' disease (n=334), type 1 diabetes mellitus (n=252) and healthy controls (n=320) were genotyped for the promoter (-1260) C/A polymorphism and for the intron 6 (+2838) C/T polymorphism of the CYP27B1 gene. Patients and controls were compared using genotype-wise and allele-wise X(2) testing. RESULTS: A significant association was found between allelic variation of the promoter (-1260) C/A polymorphism and Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus (P=0.0062, P=0.0173, P=0.0094 and P=0.0028 respectively). Significant differences were also observed for the intron 6 (+2838) C/T polymorphism (P=0.0058) in Hashimoto's thyroiditis but not for the other autoimmune endocrine diseases. CONCLUSIONS: The CYP27B1 promoter (-1260) C/A polymorphism appears to be associated with endocrine autoimmune diseases but the CYP27B1 intron 6 (+2838) C/T polymorphism appears to be associated only with Hashimoto's thyroiditis. These results imply a regulatory difference of the CYP27B1 hydroxylase to predispose to endocrine autoimmunity.


2007 ◽  
Vol 157 (6) ◽  
pp. 757-761 ◽  
Author(s):  
Z Gombos ◽  
R Hermann ◽  
M Kiviniemi ◽  
S Nejentsev ◽  
K Reimand ◽  
...  

ObjectiveAddison's disease is an organ-specific autoimmune disorder with a polygenic background. The aim of the study was to identify non-class II human leukocyte antigen (HLA) susceptibility genes for Addison's disease.Design and methodsAddison's disease patients from three European populations were analysed for selected HLA–DR–DQ alleles and for 11 microsatellite markers covering ∼4 Mb over the HLA region. Subjects were 69 patients with Addison's disease from Estonia (24), Finland (14) and Russia (31). Consecutively recruited healthy newborns from the same geographical regions were used as controls (269 Estonian, 1000 Finnish and 413 Russian). Association measures for HLA–DRB1, DQB1, DQA1 and 11 microsatellites between D6S273 and D6S2223 were taken. A low-resolution full-house typing was used for HLA class II genes, while microsatellite markers were studied using fluorescence-based DNA fragment sizing technology.ResultsWe confirmed that the HLA–DR3–DQ2 and the DQB1*0302–DRB1*0404 haplotypes confer disease susceptibility. In Russian patients, we also found an increase of DRB1*0403 allele, combined with DQB1*0305 allele in three out of six cases (P<0.0001). Analysis of 11 microsatellite markers including STR MICA confirmed the strong linkage in DR3–DQ2 haplotypes but DRB1*0404–DQB1*0302 haplotypes were diverse. MICA5.1 allele was found in 22 out of 24 Estonian patients, but results from Finnish and Russian patients did not support its independent role in disease susceptibility.ConclusionHLA–DRB1*0403 was identified as a novel susceptibility allele for Addison's disease. Additionally, we found no evidence of a non-class II HLA disease susceptibility locus; however, the HLA–DR3–DQ2 haplotype appeared more conserved in patient groups with high DR–DQ2 frequencies.


2005 ◽  
Vol 34 (3) ◽  
pp. 859-863 ◽  
Author(s):  
C E Jennings ◽  
C J Owen ◽  
V Wilson ◽  
S H S Pearce

Previous studies have suggested an association between alleles of the CYP27B1 (1-α hydroxylase) gene and autoimmune conditions. We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5′ region and promoter of the CYP27B1 gene for association in a cohort of Graves’ disease and autoimmune Addison’s disease subjects from the UK. Genomic DNA samples from white patients with autoimmune Addison’s disease (n=104) and healthy controls (n=464) were genotyped by PCR-RFLP analysis for the SNPs at positions −1260 and −1077 5′ of the coding CYP27B1 sequences. The −1260 SNP was also examined in a cohort of patients with Graves’ disease (n=446). χ2 testing of contingency tables was used to determine the significance of genotypes and alleles. Haplotype frequencies and linkage disequilibrium measures were estimated using the UNPHASED and HAPLOVIEW packages. Alleles at the three CYP27B1 markers were in tight linkage disequilibrium with each other and all showed association with autoimmune Addison’s disease. The maximum evidence for association was with the −1260 C allele (76.0% in Addison’s subjects versus 64.9% in controls; P=0.003; odds ratio 1.71 (5–95% confidence intervals, 1.20–2.44). A global test of significance for the common −1918 T, −1260 C and −1077 G haplotype was significant in Addison’s subjects compared with controls (P=0.01). In contrast, there was no association of alleles at the −1260 SNP with Graves’ disease. We are able to confirm that a CYP27B1 promoter allele is associated with autoimmune Addison’s disease, and extend this finding to include an associated promoter haplotype.


1973 ◽  
Vol 72 (2) ◽  
pp. 401-416 ◽  
Author(s):  
Harald M. M. Frey ◽  
Jørgen H. Vogt ◽  
Jørgen Nerup

ABSTRACT Two family histories are presented. In the first (family W.) two siblings, aged 12 and 16, had idiopathic Addison's disease. The younger patient also had a goitre, possibly representing Hashimoto's thyroiditis. In the second family Graves' disease was present in three generations in direct succession. The oldest patient in addition had Addison's disease, diabetes mellitus and total alopecia. Organ-specific antibodies were looked for quite extensively in the serum of the patients and their relatives, with several positive findings, but without a consistent pattern. A review is given of the literature on familial poly-endocrinopathies and the probable auto-immune character of these dieases. The present cases constitute strong evidence for a genetic transmission of these diseases, and for a common basic aetiology. If this common basis is an auto-immuno aberration, it seems most reasonable, in view of the polyglandular involvement, to assume that the immune-system proper is at fault, rather than a defect in the individual organs.


Sign in / Sign up

Export Citation Format

Share Document